Furthermore, we showed that the expression of lipogenic enzymes, Acly, Acaca, and Fasn, increased in breast cancer cells, and inhibition of lipogenesis by the FASN inhibitor cerulenin completely inhibited TNBC cell growth and the sphere-forming ability (Supplementary Fig. 4a–c). The gene discussed is FASN; the disease is breast cancer.